The Epithalon + MOTS-c stack targets the two most critical pillars of cellular aging: telomere shortening and mitochondrial decline. Epithalon (AEDG peptide) activates telomerase, the enzyme that lengthens telomeres, effectively slowing the cellular clock. Discovered by Professor Vladimir Khavinson, epithalon extends lifespan in animal models and normalizes circadian rhythms. MOTS-c is a mitochondrial-derived peptide that activates AMPK, enhances mitochondrial function, and improves insulin sensitivity. Together, epithalon preserves chromosomal integrity while MOTS-c ensures cellular powerhouses remain efficient.
Epithalon (Ala-Glu-Asp-Gly) activates telomerase reverse transcriptase (hTERT), the enzyme responsible for maintaining telomere length. Telomere shortening is a primary driver of cellular aging and replicative senescence. Epithalon also regulates pineal gland function, normalizing melatonin production which declines with age, improving circadian rhythm and sleep quality.
MOTS-c is encoded in the mitochondrial genome and acts as a retrograde signal from mitochondria to the nucleus. It activates AMPK (the master metabolic regulator), promotes mitochondrial biogenesis, enhances fat oxidation, and improves insulin sensitivity. While epithalon addresses nuclear aging (telomeres), MOTS-c addresses mitochondrial aging, covering both pillars of cellular decline.
| Protocol | Compound 1 | Compound 2 | Timing | Duration |
|---|---|---|---|---|
| Standard | Epithalon 5mg/day x 10 days | MOTS-c 5mg 3x/week | AM both | Epi: 10 days, MOTS-c: 8-12 wk |
| Enhanced | Epithalon 10mg/day x 10 days | MOTS-c 5mg 5x/week | AM both | Epi: 10 days, MOTS-c: 12 wk |
| Maintenance | Epi 5mg/day x 10 days, 2x/year | MOTS-c 5mg 2x/week | AM | Ongoing cycles |
Both have excellent safety profiles with decades of research.
| Panel | Markers | Timing |
|---|---|---|
| Aging Biomarkers | Telomere length, biological age test | Baseline, 6 months |
| Metabolic | Fasting glucose, insulin, HbA1c | Baseline, Week 8 |
| Hormonal | Melatonin (urinary), cortisol (AM) | Baseline, post-epithalon |
| Basic | CBC, CMP | Baseline, Week 8 |
Telomere length testing (qPCR or FISH) tracks epithalon effects over 6-12 months. MOTS-c tracked via metabolic markers.

10 consecutive days, repeated 2-3 times per year. Khavinson research suggests these short courses sufficiently activate telomerase for months. Continuous use not recommended.
Yes, MOTS-c enhances mitochondrial metabolism and AMPK-mediated energy pathways. Subjects report improved endurance, faster recovery, and better glucose utilization. It is sometimes called the exercise mimetic peptide.
Epithalon activates telomerase to slow telomere shortening (chromosomal aging). MOTS-c activates AMPK and enhances mitochondrial function (metabolic aging). Together they target both fundamental mechanisms of cellular decline.
10 consecutive days, repeated 2-3 times per year. Khavinson research suggests these short courses sufficiently activate telomerase for months. Continuous use not recommended.
Yes, MOTS-c enhances mitochondrial metabolism and AMPK-mediated energy pathways. Subjects report improved endurance, faster recovery, and better glucose utilization. It is sometimes called the exercise mimetic peptide.
Epithalon activates telomerase to slow telomere shortening (chromosomal aging). MOTS-c activates AMPK and enhances mitochondrial function (metabolic aging). Together they target both fundamental mechanisms of cellular decline.
10 consecutive days, repeated 2-3 times per year. Khavinson research suggests these short courses sufficiently activate telomerase for months. Continuous use not recommended.
Yes, MOTS-c enhances mitochondrial metabolism and AMPK-mediated energy pathways. Subjects report improved endurance, faster recovery, and better glucose utilization. It is sometimes called the exercise mimetic peptide.